Evidence map›Paper›PMID 36143286›Full record

ArticleJournal of personalized medicine2022

Impact of Early Limitation of Therapeutic Effort in Elderly COVID-19 Patients Admitted to the Intensive Care Unit-A Cohort Study.

Thomas Lacoste-Palasset, Laetitia Sutterlin, Aymen M'Rad, Louis Modestin, Vianney Mourman, Adrien Pepin-Lehalleur, Isabelle Malissin, Giulia Naim, Caroline Grant, Emmanuelle Guérin and 4 more

Abstract read
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Thomas Lacoste-PalassetDepartment of Medical and Toxicological Critical Care, Lariboisière Hospital, APHP, 75010 Paris, France.
Laetitia SutterlinDepartment of Medical and Toxicological Critical Care, Lariboisière Hospital, APHP, 75010 Paris, France.
Aymen M'RadDepartment of Medical and Toxicological Critical Care, Lariboisière Hospital, APHP, 75010 Paris, France.
Louis ModestinDepartment of Medical and Toxicological Critical Care, Lariboisière Hospital, APHP, 75010 Paris, France.
Vianney MourmanMobile Palliative Care Team, Lariboisière Hospital, APHP, 75010 Paris, France.
Adrien Pepin-LehalleurDepartment of Medical and Toxicological Critical Care, Lariboisière Hospital, APHP, 75010 Paris, France.
Isabelle MalissinDepartment of Medical and Toxicological Critical Care, Lariboisière Hospital, APHP, 75010 Paris, France.
Giulia NaimDepartment of Medical and Toxicological Critical Care, Lariboisière Hospital, APHP, 75010 Paris, France.
Caroline GrantDepartment of Medical and Toxicological Critical Care, Lariboisière Hospital, APHP, 75010 Paris, France.
Emmanuelle GuérinDepartment of Medical and Toxicological Critical Care, Lariboisière Hospital, APHP, 75010 Paris, France.
Jean-Michel EkhérianDepartment of Medical and Toxicological Critical Care, Lariboisière Hospital, APHP, 75010 Paris, France.
Nicolas DeyeDepartment of Medical and Toxicological Critical Care, Lariboisière Hospital, APHP, 75010 Paris, France.ORCID 0000-0003-1652-1540
Bruno MégarbaneDepartment of Medical and Toxicological Critical Care, Lariboisière Hospital, APHP, 75010 Paris, France.ORCID 0000-0002-2522-2764
Sebastian VoicuDepartment of Medical and Toxicological Critical Care, Lariboisière Hospital, APHP, 75010 Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Admission to the ICU and intensity of care provided to elderly COVID-19 patients are difficult choices guided by the expected patient-centered benefits. However, the impact of an early discussion of limitation of therapeutic effort (LTE) has been poorly investigated. (2) Methods: We performed a single-center retrospective cohort study including all ≥70-year-old COVID-19 patients admitted to the ICU. Factors associated with early LTE discussion (defined as before or up to 2 days post-ICU admission) and in-hospital mortality were evaluated. (3) Results: Eighty-two patients (59 M/23 F; 78 years (74−82) [median (interquartile range)]; 43/82 with LTE) were included. The in-hospital mortality rate was 55%. Early LTE was decided upon for 22/82 patients (27%), more frequently in older (p < 0.001) and frailer patients (p = 0.004). Using a multivariable logistic regression model including clinical frailty scale grade ≥4, hospital acquisition of COVID-19, ventilation support modality and SOFA score on admission, early LTE was not associated with mortality (adjusted odds ratio = 0.57 (0.15−2.00), p = 0.39). LTE resulted in less frequent invasive mechanical ventilation (23% versus 65%, p = 0.001), renal replacement therapy (5% versus 27%, p = 0.03) and norepinephrine infusion (23% versus 60%, p = 0.005), and shorter ICU stay (6 days (2−12) versus 14 days (7−24), p = 0.001). (4) Conclusions: In this small sample exploratory study, we were unable to demonstrate any increase in in-hospital mortality associated with early LTE discussion in elderly COVID-19 patients while reducing the use of organ support techniques. These findings require confirmation in larger studies.

Indexed as

COVID-19deathelderlyfrailtyintensive care unitlimitation of therapeutic effort

Identifiers

PMID36143286
PMCPMC9501145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.